Syndax Pharmaceuticals Inc (SNDX) › Capital ExpendituresSyndax Pharmaceuticals Inc (SNDX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $4.0K2015: $49.0K2016: $261.0K2017: $84.0K2018: $187.0K2020: $02021: $129.0K2022: $02023: $02024: $02025: $187.0K$187.0K2014Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$187.0K—2024$0—2023$0—2022$0-100.0%2021$129.0K—2020$0—2018$187.0K+122.6%2017$84.0K-67.8%2016$261.0K+432.7%2015$49.0K+1125.0%2014$4.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share